Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sam who wrote (5997)	1/27/1999 10:16:00 AM
From: margie	Read Replies (1) of 6136

There is upside potential to the final price. If WLA shares average above $74 for the last 10 days before the close of the deal, the price will be higher than $60. I assume it would then be .8108 times the share price. Looks like WLA shareholders like the deal. The stock price of the acquirer usually goes down at times like this. They didn't set a date, but sooner than 3 months. As soon as possible, pending shareholder approval and standard antitrust issues. It sounds like there is a lot of mutual respect between the two sides and much admiration from Warner Lambert and Parke Davis for Agouron and it's world class science (their words.)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next